A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.

NCT03076216 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable Locally Advanced Pancreatic Carcinoma

Interventions

DEVICE: OncoSil™

Sponsor

OncoSil Medical Limited